Extracorporeal support for severe acute respiratory failure

Area of Science:

• Critical Care Medicine
• Respiratory Physiology
• Cardiopulmonary Support

Background:

• Severe acute lung injury often requires advanced respiratory support beyond conventional mechanical ventilation.
• Extracorporeal life support (ECLS) encompasses techniques like ECMO and ECCO2R.
• These methods provide temporary cardiopulmonary support when native organ function is insufficient.

Purpose of the Study:

• To review current concepts and systems for extracorporeal life support (ECMO and ECCO2R).
• To outline the rationale for using ECMO and ECCO2R in specific patient populations.
• To discuss the role of ECLS as adjunctive therapy for lung transplantation.

Main Methods:

• Review of current extracorporeal life support (ECLS) techniques.
• Analysis of clinical applications for ECMO and ECCO2R.
• Discussion of evidence supporting ECLS in ARDS, COPD, and as a bridge to transplant.

Main Results:

• ECMO and ECCO2R are increasingly used for severe acute lung injury unresponsive to standard ventilation.
• These techniques offer a rationale for application in acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD).
• ECLS serves as a crucial adjunctive therapy for bridging patients to lung transplantation.

Conclusions:

• Extracorporeal life support (ECMO and ECCO2R) represents a significant advancement in managing severe respiratory failure.
• The application of ECLS is expanding in critical care for ARDS, COPD, and pre-transplant support.
• Further research and clinical integration of ECLS are essential for optimizing patient outcomes.